ADDvise Group AB A - Asset Resilience Ratio
ADDvise Group AB A (ADDV-A) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is ADDvise Group AB A's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how ADDvise Group AB A's Asset Resilience Ratio has changed over time. See ADDV-A equity to assets ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down ADDvise Group AB A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ADDV-A market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: ADDvise Group AB A maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
ADDvise Group AB A Industry Peers by Asset Resilience Ratio
Compare ADDvise Group AB A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.87% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Tarsons Products Limited
NSE:TARSONS |
Medical Instruments & Supplies | 0.47% |
|
SciVision Biotech Inc
TW:1786 |
Medical Instruments & Supplies | 7.81% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Annual Asset Resilience Ratio for ADDvise Group AB A (2014–2024)
The table below shows the annual Asset Resilience Ratio data for ADDvise Group AB A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 3.57% | Skr123.20 Million ≈ $13.26 Million |
Skr3.45 Billion ≈ $370.92 Million |
+4.23pp |
| 2022-12-31 | -0.65% | Skr-12.88 Million ≈ $-1.39 Million |
Skr1.97 Billion ≈ $211.87 Million |
+0.67pp |
| 2021-12-31 | -1.32% | Skr-14.12 Million ≈ $-1.52 Million |
Skr1.07 Billion ≈ $115.09 Million |
-- |
| 2019-12-31 | 0.00% | Skr0.00 ≈ $0.00 |
Skr360.37 Million ≈ $38.78 Million |
-- |
| 2018-12-31 | 2.59% | Skr7.53 Million ≈ $810.78K |
Skr291.22 Million ≈ $31.34 Million |
-4.94pp |
| 2017-12-31 | 7.53% | Skr20.90 Million ≈ $2.25 Million |
Skr277.70 Million ≈ $29.88 Million |
-3.69pp |
| 2016-12-31 | 11.22% | Skr25.19 Million ≈ $2.71 Million |
Skr224.48 Million ≈ $24.16 Million |
+6.65pp |
| 2015-12-31 | 4.57% | Skr5.89 Million ≈ $634.40K |
Skr128.95 Million ≈ $13.88 Million |
-14.87pp |
| 2014-12-31 | 19.44% | Skr32.38 Million ≈ $3.48 Million |
Skr166.55 Million ≈ $17.92 Million |
-- |
About ADDvise Group AB A
ADDvise Group AB (publ) supplies medical devices, equipment, and consumables to public and private laboratories and research facilities, healthcare, and pharmaceuticals in North America, Europe, South America, Sweden, and internationally. The company provides laboratory furniture, protective ventilation systems, climate-controlled clean rooms, and laboratory equipment; and develops and supplies m… Read more